Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessment.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: John P. Curtin Franco Muggia |
| Publication date | September 15, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |